Advertisement

Topics

Pfizer Prices €4,000,000,000 Debt Offering

18:53 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Pfizer Inc. (NYSE:PFE) today announced the pricing of a debt offering consisting of four tranches of notes: €1,250,000,000 aggregate principal amount of floating rate notes due 2019 €1,000,000,000 aggregate...

Other Sources for this Article

Pfizer Inc.
Media Relations:
Joan Campion, 212-733-2798
or
Investor Relations:
Ryan Crowe, 212-733-8160

NEXT ARTICLE

More From BioPortfolio on "Pfizer Prices €4,000,000,000 Debt Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...